Paksu S, Duran L, Altuntas M, Zengin H, Salis O, Ozsevik S N, Albayrak H, Murat N, Guzel A, Paksu M S
Department of Pediatrics, Faculty of Medicine, Ondokuz Mayis University, Atakum, Samsun, Turkey.
Department of Emergency Medicine, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Hum Exp Toxicol. 2014 Sep;33(9):980-90. doi: 10.1177/0960327113520019. Epub 2014 Feb 6.
The purpose of this study was to evaluate the patients with acute amitriptyline poisoning and investigate predictive factors for the development of life-threatening complications.
Demographics, clinical, laboratory, and electrocardiographic (ECG) findings of 250 patients were evaluated retrospectively. Predictive parameters for the development of serious complications were studied.
Median age of patients was 14.6 years, of which, 70% of patients were female and 66% were in pediatric age group. The most common pathological clinical finding and laboratory abnormality were alteration of consciousness and hyponatremia. The rate of convulsive seizure, arrhythmia, and respiratory depression were 17 (6.8%), 16 (6.4%), and 11 (4.4%), respectively. These complications were more seen in pediatric patients than adults (15.8% and 1.2%). The incidence of hyponatremia was more in pediatric patients and severe poisoning groups (38.8 and 53.4%, respectively). The levels of amitriptyline and nortriptyline were significantly higher in the group with complications than the group without complications (p < 0.05). All adult patients were discharged with good prognosis. In pediatric age group, one patient was discharged with severe neurological sequelae and one patient died. QRS duration >100 ms, long corrected QT duration interval, and low Glasgow Coma Score (GCS) at admission were identified as independent risk factors for the development of life-threatening complications (odds ratio: 69.4, 1.9, and 1383, respectively; p < 0.05).
Amitriptyline poisoning may be associated with life-threatening complications, especially in pediatric age group and in patients with hyponatremia. Low GCS, presence of hyponatremia, high serum drug levels, and pathological ECG findings on admission may be helpful in predicting the development of complications and poor prognosis.
本研究旨在评估急性阿米替林中毒患者,并调查危及生命并发症发生的预测因素。
回顾性评估250例患者的人口统计学、临床、实验室及心电图(ECG)检查结果。研究严重并发症发生的预测参数。
患者的中位年龄为14.6岁,其中70%为女性,66%属于儿童年龄组。最常见的病理临床发现和实验室异常分别是意识改变和低钠血症。惊厥性癫痫发作、心律失常和呼吸抑制的发生率分别为17例(6.8%)、16例(6.4%)和11例(4.4%)。这些并发症在儿童患者中比成人中更常见(分别为15.8%和1.2%)。低钠血症的发生率在儿童患者和重度中毒组中更高(分别为38.8%和53.4%)。有并发症组的阿米替林和去甲替林水平显著高于无并发症组(p<0.05)。所有成年患者均预后良好出院。在儿童年龄组中,1例患者出院时伴有严重神经后遗症,1例患者死亡。入院时QRS时限>100 ms、校正QT间期延长和格拉斯哥昏迷评分(GCS)低被确定为危及生命并发症发生的独立危险因素(比值比分别为69.4、1.9和1383;p<0.05)。
阿米替林中毒可能与危及生命的并发症相关,尤其是在儿童年龄组和低钠血症患者中。入院时低GCS、低钠血症、高血清药物水平及病理性ECG表现可能有助于预测并发症的发生及预后不良。